Acasti Pharma is a biopharmaceutical company dedicated to developing innovative, evidence-based therapies for cardiovascular diseases. Its lead product, CaPre, is a novel omega-3 phospholipid therapeutic that has shown promising results in reducing triglycerides and improving cardiovascular health. Acasti Pharma's commitment to advancing cardiovascular care through groundbreaking research and development makes it a pioneer in the pharmaceutical industry.
